Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$13.2 - $17.76 $191,400 - $257,520
14,500 New
14,500 $257,000
Q4 2021

Feb 11, 2022

BUY
$24.14 - $35.18 $913,578 - $1.33 Million
37,845 Added 224.07%
54,735 $1.37 Million
Q2 2021

Aug 16, 2021

SELL
$26.34 - $46.62 $100,092 - $177,156
-3,800 Reduced 18.37%
16,890 $488,000
Q1 2021

May 13, 2021

BUY
$45.96 - $68.02 $950,912 - $1.41 Million
20,690 New
20,690 $1.05 Million

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.